GGrantIndex
← Leaderboards

Kristin I Stanford

Ohio State University

$6,188,806
Attributed
$10,534,038
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,534,038 · 7

By mechanism

R01$9,564,491 · 4
R56$450,310 · 1
K01$420,305 · 1
F32$98,932 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Metabolic

Research focus

MetabolicLipidsObesityBrown FatTissue TransplantationExerciseTissuesSignal TransductionMitochondriaGlucoseComorbidityCombatInsulin SensitivityOxidationMetabolismAdipose TissueUptakeTransplantationMediatingResponseAffectNon-Insulin-Dependent Diabetes MellitusCardiovascular DiseasesEnergy Metabolism

Grant awards (24)

Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress$785,561
R01 · FY2025 · HL
Engineering the release of oxylipins through the skin$641,396
R01 · FY2025 · DK · contact PI
Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress$769,850
R01 · FY2024 · HL
Engineering the release of oxylipins through the skin$616,063
R01 · FY2024 · DK · contact PI
Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress$785,561
R01 · FY2023 · HL
Engineering the release of oxylipins through the skin$606,321
R01 · FY2023 · DK · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.$579,592
R01 · FY2023 · AG · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.$601,884
R01 · FY2022 · AG · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.$599,696
R01 · FY2021 · AG · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$385,972
R01 · FY2021 · HL · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.$623,704
R01 · FY2020 · AG · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$385,953
R01 · FY2020 · HL · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.$621,676
R01 · FY2019 · AG · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$385,935
R01 · FY2019 · HL · contact PI
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence$450,310
R56 · FY2018 · AG · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$392,338
R01 · FY2018 · HL · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$390,000
R01 · FY2018 · HL · contact PI
A Novel Role for Brown Adipose Tissue Enhance Heart Function and Metabolism$392,989
R01 · FY2017 · HL · contact PI
Novel mechanisms for the stromal vascular fraction of brown adipose tissue to improve metabolic homeostasis$142,032
K01 · FY2017 · DK · contact PI
Novel mechanisms for the stromal vascular fraction of brown adipose tissue to improve metabolic homeostasis$142,032
K01 · FY2016 · DK · contact PI
Novel mechanisms for the stromal vascular fraction of brown adipose tissue to improve metabolic homeostasis$82,706
K01 · FY2015 · DK · contact PI
Novel mechanisms for the stromal vascular fraction of brown adipose tissue to improve metabolic homeostasis$53,535
K01 · FY2015 · DK · contact PI
Novel Roles of Adipose Tissue in Exercise Training Effects on Glucose Homeostasis$51,326
F32 · FY2011 · DK · contact PI
Novel Roles of Adipose Tissue in Exercise Training Effects on Glucose Homeostasis$47,606
F32 · FY2010 · DK · contact PI